Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Endocrine
|
June 25, 2022
Somatostatin receptor-directed molecular imaging for therapeutic decision-making in patients with medullary thyroid carcinoma
Sebastian E Serfling, Yingjun Zhi, Felix Megerle, et al.
Endocrine
|
December 22, 2023
[<sup>18</sup>F]FDG PET/CT can trigger relevant oncological management changes leading to favorable outcome in iodine-negative thyroid cancer patients
Yingjun Zhi, Takahiro Higuchi, Stephan Hackenberg, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 16, 2026
CXCR4-targeted PET/CT in early systemic sclerosis-associated interstitial lung disease: a prospective proof-of-concept study of in vivo inflammatory activity
Michael Gernert, Marc Schmalzing, Hannah Labinsky, et al.
Clinical Nuclear Medicine
|
April 19, 2022
Interobserver Agreement Rates on Fibroblast Activation Protein Inhibitor-Directed Molecular Imaging and Therapy
Sebastian E Serfling, Philipp E Hartrampf, Yingjun Zhi, et al.
Clinical Nuclear Medicine
|
February 8, 2023
Somatostatin Receptor-Directed PET/CT for Therapeutic Decision-Making and Disease Control in Patients Affected With Small Cell Lung Cancer
Sebastian E Serfling, Philipp E Hartrampf, Yingjun Zhi, et al.
Cancers
|
May 13, 2026
Impact of Neuroendocrine Neoplasm-Specific Systemic Treatments on Somatostatin Receptors Expression and Function in Neuroendocrine Tumor Cells
Christof Däubler, Clara Böttcher, Laura-Sophie Landwehr, et al.
Clinical Nuclear Medicine
|
March 3, 2025
Somatostatin Receptor-Directed Theranostics in Esthesioneuroblastoma
Yingjun Zhi, Sebastian E Serfling, Daniel Groener, et al.
American Journal of Nuclear Medicine and Molecular Imaging
|
November 29, 2023
Diagnostic efficacy of C-X-C motif chemokine receptor 4-directed PET/CT in newly diagnosed head and neck squamous cell carcinoma - a head-to-head comparison with [<sup>18</sup>F]FDG
Yingjun Zhi, Rudolf A Werner, Andreas Schirbel, et al.
Frontiers in Immunology
|
April 3, 2026
[<sup>18</sup>F]-FDG-PET/CT detects subclinical optic nerve inflammation in giant cell arteritis
Michael Gernert, Marc Schmalzing, Matthias Fröhlich, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 29, 2021
Targeting fibroblast activation protein in newly diagnosed squamous cell carcinoma of the oral cavity - initial experience and comparison to [<sup>18</sup>F]FDG PET/CT and MRI
Christian Linz, Roman C Brands, Olivia Kertels, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Endocrine
|
June 25, 2022
Somatostatin receptor-directed molecular imaging for therapeutic decision-making in patients with medullary thyroid carcinoma
Sebastian E Serfling, Yingjun Zhi, Felix Megerle, et al.
Endocrine
|
December 22, 2023
[<sup>18</sup>F]FDG PET/CT can trigger relevant oncological management changes leading to favorable outcome in iodine-negative thyroid cancer patients
Yingjun Zhi, Takahiro Higuchi, Stephan Hackenberg, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 16, 2026
CXCR4-targeted PET/CT in early systemic sclerosis-associated interstitial lung disease: a prospective proof-of-concept study of in vivo inflammatory activity
Michael Gernert, Marc Schmalzing, Hannah Labinsky, et al.
Clinical Nuclear Medicine
|
April 19, 2022
Interobserver Agreement Rates on Fibroblast Activation Protein Inhibitor-Directed Molecular Imaging and Therapy
Sebastian E Serfling, Philipp E Hartrampf, Yingjun Zhi, et al.
Clinical Nuclear Medicine
|
February 8, 2023
Somatostatin Receptor-Directed PET/CT for Therapeutic Decision-Making and Disease Control in Patients Affected With Small Cell Lung Cancer
Sebastian E Serfling, Philipp E Hartrampf, Yingjun Zhi, et al.
Cancers
|
May 13, 2026
Impact of Neuroendocrine Neoplasm-Specific Systemic Treatments on Somatostatin Receptors Expression and Function in Neuroendocrine Tumor Cells
Christof Däubler, Clara Böttcher, Laura-Sophie Landwehr, et al.
Clinical Nuclear Medicine
|
March 3, 2025
Somatostatin Receptor-Directed Theranostics in Esthesioneuroblastoma
Yingjun Zhi, Sebastian E Serfling, Daniel Groener, et al.
American Journal of Nuclear Medicine and Molecular Imaging
|
November 29, 2023
Diagnostic efficacy of C-X-C motif chemokine receptor 4-directed PET/CT in newly diagnosed head and neck squamous cell carcinoma - a head-to-head comparison with [<sup>18</sup>F]FDG
Yingjun Zhi, Rudolf A Werner, Andreas Schirbel, et al.
Frontiers in Immunology
|
April 3, 2026
[<sup>18</sup>F]-FDG-PET/CT detects subclinical optic nerve inflammation in giant cell arteritis
Michael Gernert, Marc Schmalzing, Matthias Fröhlich, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 29, 2021
Targeting fibroblast activation protein in newly diagnosed squamous cell carcinoma of the oral cavity - initial experience and comparison to [<sup>18</sup>F]FDG PET/CT and MRI
Christian Linz, Roman C Brands, Olivia Kertels, et al.
Page
of 2